Literature DB >> 34476673

circRNA Regulates Dopaminergic Synapse, MAPK, and Long-term Depression Pathways in Huntington Disease.

Ernesto Marfil-Marin1, Mónica Santamaría-Olmedo1, Adriana PerezGrovas-Saltijeral1, Margarita Valdes-Flores1, Adriana Ochoa-Morales2, Aurelio Jara-Prado2, Rosalba Sevilla-Montoya3, Alejandra Camacho-Molina4,5, Alberto Hidalgo-Bravo6.   

Abstract

Huntington disease (HD) is the most common neurogenetic disorder caused by expansion of the CAG repeat in the HTT gene; nevertheless, the molecular bases of the disease are not fully understood. Non-coding RNAs have demonstrated to be involved in the physiopathology of HD. However, the role of circRNAs has not been investigated. The aim of this study was to identify the circRNAs with differential expression in a murine cell line model of HD and to identify the biological pathways regulated by the differentially expressed circRNAs. CircRNA expression was analyzed through a microarray, which specifically detects circular species of RNA. The expression patterns between a murine cell line expressing mutant Huntingtin and cells expressing wild-type Huntingtin were compared. We predicted the miRNAs with binding sites for the differentially expressed circRNAs and the corresponding target genes for those miRNAs. Using the target genes, we performed a function enrichment analysis. We identified 23 circRNAs differentially expressed, 19 downregulated and four upregulated. Most of the downregulated circRNAs derive from the Rere gene. The dopaminergic synapse, MAPK, and long-term depression pathways were significantly enriched. The three identified pathways have been previously associated with the physiopathology of HD. The understanding of the circRNA-miRNA-mRNA network involved in the molecular mechanisms driving HD can lead us to identify novel biomarkers and potential therapeutic targets. To the best of our knowledge, this is the first study analyzing circRNAs in a model of Huntington disease.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Dopaminergic synapse pathway; Huntington disease; MAPK pathway; Mutant huntingtin; circRNA

Mesh:

Substances:

Year:  2021        PMID: 34476673     DOI: 10.1007/s12035-021-02536-1

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  2 in total

Review 1.  Dysfunctional striatal dopamine signaling in Huntington's disease.

Authors:  Ellen T Koch; Lynn A Raymond
Journal:  J Neurosci Res       Date:  2019-07-15       Impact factor: 4.164

2.  Downregulation of microRNA-15b-5p Targeting the Akt3-Mediated GSK-3β/β-Catenin Signaling Pathway Inhibits Cell Apoptosis in Parkinson's Disease.

Authors:  Jianzhong Zhu; Xue Xu; Yingyin Liang; Ronglan Zhu
Journal:  Biomed Res Int       Date:  2021-01-06       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.